Cytidine-5'-Monophosphate
- Generic Name
- Cytidine-5'-Monophosphate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H14N3O8P
- CAS Number
- 63-37-6
- Unique Ingredient Identifier
- F469818O25
- Background
A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase.
- Associated Conditions
- -
- Associated Therapies
- -
Aspirin is associated with lower risk of pancreatic cancer and cancer-related mortality in patients with diabetes mellitus
A study of 343,966 T2DM patients in Hong Kong (2001-2015) found aspirin use linked to reduced pancreatic cancer (PC) risk (aHR: 0.58), PC-related mortality (aHR: 0.43), and all-cause mortality (aHR: 0.78), with benefits increasing with dose and duration.
Exploring the connection between EU-funded research and methodological approaches
AD incidence in Europe increased from 1999 to 2019; BC is the most diagnosed cancer in the EU. Measuring societal impact of research is complex, involving health gains, new medicines, and job creation. Animal and non-animal research methods were analyzed in EU-funded AD, BC, and PC projects. Human-based approaches are deemed highly relevant for societal impact. Innovations like organ-on-chip and in silico tools show translational potential. Despite challenges, non-animal methods are increasingly used, especially in diagnostic tool development and clinical trials.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath